ABBV vs OPY · P/E 81, rev $61.16B vs P/E 13, rev $1.43B
AbbVie Inc (ABBV) versus Oppenheimer Holdings Inc (OPY) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Oppenheimer Holdings Inc (OPY) is a capital markets company listed on NYSE.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported OPY revenue for 2024-12-31 was $1.43B. Net income was $71.2M. Revenue was up 14.7% from 2023-12-31 to 2024-12-31. OPY currently screens at market cap $1.15B and trailing P/E 12.8.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. OPY currently screens at market cap $1.15B and trailing P/E 12.8.
Not investment advice. Open the ABBV and OPY stock pages for the full models.
Not investment advice.